Objective
Silvercatpharma project aims at developing C-C cross-coupling reactions catalysed by d11-blocks metals, particularly silver, for the synthesis of pharmaceuticals in Novartis. It strives to have an impact in terms of cost, environment and international visibility because of the use of silver as an alternative catalyst. The project offers me a great opportunity to obtain further training, such as clusters preparation, computational and flow chemistry, and to define my final career in academia or industry because of the possibility of working in these two different environments.
Fields of science
- natural scienceschemical sciencesorganic chemistry
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugs
- medical and health sciencesbasic medicinemedicinal chemistry
- natural scienceschemical sciencesinorganic chemistrytransition metals
- natural scienceschemical sciencescatalysis
Programme(s)
Funding Scheme
MSCA-IF-EF-ST - Standard EFCoordinator
FUNDACIO PRIVADA INSTITUT CATALA D'INVESTIGACIO QUIMICA
Net EU contribution
€ 158 121,60
Address
AVENIDA PAISSOS CATALANS 16
43007 Tarragona
Spain
43007 Tarragona
Spain
Region
Este
Cataluña
Tarragona
Activity type
Research Organisations
Links
Total cost
€ 158 121,60